Trial Profile
A Randomized Trial of Sirolimus (Rapamune(R)) for Relapse Prevention in Patients With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Apr 2024
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 14 Sep 2023 Planned End Date changed from 31 Aug 2023 to 31 Aug 2024.
- 14 Sep 2023 Planned primary completion date changed from 31 Aug 2023 to 31 Aug 2024.
- 06 Dec 2016 New trial record